Latest Tariff Impacts News

Yowie Group Ltd has firmly rejected the validity of director removal and nomination notices purportedly from Keybridge Capital, while confirming its status as Keybridge’s largest creditor with over $6.6 million owed. The company also detailed a recent share placement amid ongoing regulatory scrutiny.

Yowie Group intensifies efforts to reclaim a substantial loan from Keybridge Capital, issuing a statutory demand and launching a share placement to shore up finances amid tariff challenges.

Coronado Global Resources Inc. posted a $96.2 million net loss for Q1 2025, reflecting weak metallurgical coal prices and ongoing liquidity challenges. The company is navigating covenant waivers and pursuing refinancing amid market uncertainty.

Light & Wonder, Inc. reported a steady 2% revenue rise in Q1 2025, marking its 16th consecutive quarter of growth, alongside margin expansion and a $166 million share buyback. The company is on track to close its strategic $850 million acquisition of Grover Gaming’s charitable business.

ARN Media Limited’s 2025 AGM update highlights robust financial health, a strategic $40 million transformation program, and strong digital audio momentum despite a modest revenue dip year-to-date.

ARN Media reports resilient 2024 financials driven by digital growth and Cody Outdoor contracts, launching a major cost-cutting transformation to sharpen its competitive edge.

Gale Pacific has sharply downgraded its full-year EBITDA guidance due to tariff-driven demand softness in the US, while its Australia, New Zealand, and developing markets hold steady.

Reliance Worldwide Corporation outlines its strategic response to US tariffs, emphasizing diversified sourcing and price adjustments to sustain margins in a $25.3 billion plumbing market. The company forecasts broadly flat FY25 sales with slight margin pressure but remains confident in long-term growth.

Reliance Worldwide Corporation updates on the financial impact of new US tariffs, outlining a multi-pronged mitigation strategy and revising its FY25 sales outlook amid market uncertainty.

Cardiex reports strong early sales momentum for its CONNEQT Pulse device with approximately 3,000 units sold or contracted since its mid-January launch, supported by innovative app features and operational efficiencies. Despite regulatory delays in the US pharma sector and tariff challenges, the company is positioned for scalable growth and category leadership in preventative cardiovascular care.

SomnoMed Limited reported a robust 23.2% revenue increase in Q3 FY25, reaffirming its full-year guidance while actively addressing new US tariffs through potential duty-free exemptions.

Atomos Limited reported a $2.3 million operating cash outflow in Q3 FY25 amid seasonal softness and tariff challenges, while announcing a leadership change and a bold expansion into new product categories beyond its core monitor-recorder business.